Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: Pathologic and prognostic correlations

Cancer

Volumn 82, Issue 8, 1998, Pages 1495-1500

  Vargas, Sara O ^a,d   Leslie, Kevin O ^a,e   Vacek, Pamela M ^b   Socinski, Mark A ^c   Weaver, Donald L ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Bronchogenic carcinoma; Estrogen receptor; Estrogen receptor related protein; Immunohistochemistry; Lung; Nonsmall cell carcinoma; p29; Survival analysis

Indexed keywords

BIOTIN; ESTROGEN RECEPTOR; PROTEIN P29; RECEPTOR PROTEIN; STREPTAVIDIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

EID: 0032523058     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19980415)82:8<1495::aid-cncr10>3.0.co;2-%23     Document Type: Article

References (42)

1. Alford TC, Do HM, Geelhoad GW, Tsangaris NT, Lippman ME. Steroid hormone receptor in human colon cancers. Cancer 1979;43:980-4.
2. Fisher RI, Neifeld JP, Lippman ME. Oestrogen receptors in human malignant melanoma. Lancet 1976;2:337-9.
3. Francavilla A, DiLeo A, Polimeno L, Conte D, Barone M, Fanizza G, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 1987;93:1301-6.
4. Fujimoto M, Yoshino E, Hirakawa K, Fujimoto J, Tamaya T. Estrogen receptors in brain tumors. Clin Neuropharmacol 1984;7(4):357-62.
5. Greenway B, Iqbal MJ, Johnson PJ, Williams R. Oestrogen receptor proteins in malignant and fetal pancreas. BMJ 1981;283:751-3.
6. Henry JA, Bennett MK, Piggott NH, Levett DL, May FEB, Westley BR. Expression of the pN-2/pS2 protein in diverse human epithelial tumors. Br J Cancer 1991;64:677-82.
7. Kobayashi S, Mizuno T, Tobioko N, Ichimura H, Samoto T, Tanaka H. Sex steroid receptors in diverse human tumors. Gann 1982;73:439-45.
8. Lugmani YA, Ryall G, Shousha S, Coombes RC. An immunohistochemical survey of pS2 expression in human epithelial cancers. Int J Cancer 1992;50:302-4.
9. Ollayos CW, Riordan GP, Rushin JM. Estrogen receptor detection in paraffin sections of adenocarcmoma of the colon, pancreas, and lung. Arch Pathol Lab Med 1994; 118:630-2.
10. Sica V, Nola E, Contiere E, Bova R, Masucci MT, Medici N. Estradiol and progesterone receptors in malignant gastrointestinal tumours. Cancer Res 1984;44:4670-4.
11. Sledman KE, Moog GE, Morgan RT. Estrogen receptor proteins in diverse human tumors. Arch Surg 1980;115:244-8.
12. Szabo I, Lanyi E, Vertes M, Csaba I. Glucocorticoid and estradiol receptors in human fetal lung. J Perinat Med 1991; 19(Suppl 1):408-13.
13. Takeda H, Yamakawam M, Takahashi T, Imai Y, Ishikawa M. An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer. Cancer 1992;69:907-12.
14. Tokunaga A, Nishi K, Matsukura N, Tanaka N, Onda M, Shirota A. Estrogen and progesterone receptors in gastric cancer. Cancer 1986;57:1376-9.
15. Yamamoto M, Nakajo S, Tahara E. Immunohistochemical analysis of estrogen receptors in human gallbladder. Acta Pathol Jpn 1990;40:14-21.
16. Zheng S. Estrogen receptor content in human embryo [Chinese with English abstract]. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1990;12(4):246-51.
17. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res 1985;45:4206-14.
18. Cagle PT, Mody DR, Schwartz MR. Estrogen and progesterone receptors in bronchogenic carcinoma. Cancer Res 1990;50:6632-5.
19. Chadhuri PK, Thomas PA, Walker MJ, Briele HA, DasGupta TK, Beattie CW. Steroid receptors in human lung cancer. Cancer Lett 1982;16:327-32.
20. Gershtein ES, Smirnova KD, Polotskii BE, Kuz'mina ZV, Vavydov MI. Steroid hormone receptors in lung cancer tissue [Russian with English abstract]. Vopr Onkol 1990;36:1439-42.
21. Jones LA, Blocker SH, Rusch VH, Mountain CF. Specific estrogen binding protein in human lung cancer. Proc Am Assoc Cancer Res 1984;25:208.
22. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM Jr. Sex-hormone receptors in non-small-cell lung cancer in human beings. J Thorac Cardiovasc Surg 1994; 108:153-7.
23. Raab SR, Berg LC, Swanson PE, Wick MR. Adenocarcinoma in the lung in patients with breast cancer: a prospective analysis of the discriminatory value of immunohistology. Am J Clin Pathol 1993;100:27-35.
24. Deamant FD, Pombo MT, Battifora H. Estrogen receptor immunohistochemistry as a predictor of site of origin in metastatic breast cancer. Appl Immunohistochem 1993; 1:188-92.
25. Mathew P, Frytak S, Colby T. Estrogen and progesterone receptors in bronchoalveolar carcinoma [meeting abstract]. Proc Annu Meet Am Assoc Cancer Res 1994;35:A1247.
26. Allred DC, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunocytochemical analysis of estrogen receptors in human breast carcinomas: Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch Surg 1990;125:107-13.
27. Kauppila A. Oestrogen and progestin receptors as prognostic indicators in endometrial cancer: a review of the literature. Acta Oncol 1989;28:561-6.
28. Harrison JD, Morris DL, Ellis IO, Jones JA, Jackson I. The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 1989;64:1007-10.
29. Yang MH. Estrogen receptor in female lung carcinoma [Chinese with English abstract]. Chung Hua Chieh Ho Ho Hu Hsi Tsa Chih 1992;15:138-40, 189.
30. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. Philadelphia: J.B. Lippincott, 1992.
31. World Health Organization. Histologic typing of lung tumours. 2nd edition. Geneva: World Health Organization, 1981.
32. Coffer AI, Lewis KM, Brokas AJ, King RJB. Monoclonal antibodies against a component related to soluable estrogen receptor. Cancer Res 1985;45:3686-93.
33. Coffer AI, Spiller GH, Lewis KM, King RJB. Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor. Cancer Res 1985; 45:3694-8.
34. King RJB, Finley JR, Coffer AL, Millis RR, Rubens RD. Characterization and biological relevance of a 29 kDa, estogen receptor-related protein. J Steroid Biochem Mol Biol 1987; 27(1-3);471-5.
35. Cano A, Coffer AI, Adatia R, Millis RR, Rubens RD, King RJB. Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cancer Res 1986;46:6475-80.
36. Rivera J, Hill NC, Lopez-Bernal A, Mackenzie IZ, Cano A. p29, an oestrogen receptor-associated protein, is down-regulated by mifepristone in first trimester human placenta and decidua. Hum Reprod 1991;6(9):1338-41.
37. Lee YT. Better prognosis of many cancers in female: a phenomenon not explained by study of steroid receptors. J Surg Oncol 1984;25:255-62.
38. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-9.
39. Noronha RF, Goodall CM. The effects of estrogen on single dose dimethylnitrosamine carcinogenesis in male inbred Crl/CDF rats. Carcinogenesis 1984;5:1003-7.
40. DeVesa SS, Silverman DT. Protective effect of oestrogen in pancreatic cancer. Lancet 1988;2:905-6.
41. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Morikawa S. Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 1989;64:88-93.
42. Stein B, Dougherty D, Takita H, Antkowiak J, Kunz J, Raghavan D. Bronchogenic carcinoma in patients (pts) aged less than 40 yr: changing demography [meeting abstract]. Proc Annu Meet Am Soc Clin Oncol 1993;12:A1141.